Geratherm Medical (0EL9) Ratios
Geratherm Medical Ratios
GB:0EL9's free cash flow for Q2 2026 was $24.00K. For the 2026 fiscal year, GB:0EL9's free cash flow was decreased by $-64.00K and operating cash flow was $88.00K. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Mar 22 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 6.41 | 5.21 | 2.93 | 10.67 | 2.33 |
| Quick Ratio | 4.99 | 3.55 | 1.61 | 7.13 | 1.31 |
| Cash Ratio | 2.97 | 2.16 | 0.74 | 4.00 | 0.27 |
| Solvency Ratio | 0.05 | 0.33 | 0.22 | 0.15 | 0.12 |
| Operating Cash Flow Ratio | 0.54 | 0.53 | 0.20 | 1.19 | 0.11 |
| Short-Term Operating Cash Flow Coverage | 0.86 | 1.15 | 0.00 | 0.00 | 0.32 |
| Net Current Asset Value | $ 9.85M | $ 10.81M | $ 7.78M | $ 7.16M | $ 3.68M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.10 | 0.11 | 0.20 | 0.24 | 0.27 |
| Debt-to-Equity Ratio | 0.13 | 0.16 | 0.32 | 0.42 | 0.50 |
| Debt-to-Capital Ratio | 0.11 | 0.13 | 0.24 | 0.29 | 0.33 |
| Long-Term Debt-to-Capital Ratio | 0.11 | 0.07 | 0.24 | 0.29 | 0.24 |
| Financial Leverage Ratio | 1.32 | 1.36 | 1.60 | 1.72 | 1.87 |
| Debt Service Coverage Ratio | -0.04 | 1.53 | 23.15 | 15.26 | 0.74 |
| Interest Coverage Ratio | -16.89 | 16.27 | 11.09 | 7.73 | 4.12 |
| Debt to Market Cap | 0.26 | 0.17 | 0.25 | 0.34 | 0.21 |
| Interest Debt Per Share | 0.47 | 0.63 | 1.36 | 1.74 | 1.91 |
| Net Debt to EBITDA | 33.19 | -1.49 | 0.48 | 0.17 | 3.21 |
| Profitability Margins | |||||
| Gross Profit Margin | 15.95% | 62.59% | 29.93% | 24.68% | 66.24% |
| EBIT Margin | -8.84% | 5.34% | 11.82% | 7.33% | 1.96% |
| EBITDA Margin | -1.04% | 14.44% | 19.97% | 13.04% | 8.92% |
| Operating Profit Margin | -8.84% | 8.63% | 8.09% | 5.36% | 2.39% |
| Pretax Profit Margin | -6.10% | 4.81% | 11.03% | 6.63% | 1.25% |
| Net Profit Margin | -5.51% | 3.45% | 5.30% | 3.96% | 0.50% |
| Continuous Operations Profit Margin | -5.57% | 3.20% | 7.95% | 4.19% | 1.35% |
| Net Income Per EBT | 90.30% | 71.81% | 48.09% | 59.71% | 39.73% |
| EBT Per EBIT | 69.05% | 55.68% | 136.23% | 123.60% | 52.17% |
| Return on Assets (ROA) | -3.15% | 2.47% | 3.11% | 2.67% | 0.35% |
| Return on Equity (ROE) | -4.17% | 3.35% | 4.98% | 4.58% | 0.66% |
| Return on Capital Employed (ROCE) | -5.61% | 7.06% | 5.93% | 3.83% | 2.26% |
| Return on Invested Capital (ROIC) | -4.79% | 4.50% | 4.27% | 2.42% | 2.02% |
| Return on Tangible Assets | -3.38% | 2.62% | 3.57% | 3.00% | 0.40% |
| Earnings Yield | -5.24% | 3.74% | 3.80% | 3.77% | 0.29% |
| Efficiency Ratios | |||||
| Receivables Turnover | 11.75 | 15.35 | 12.51 | 8.68 | 6.03 |
| Payables Turnover | 18.76 | 9.54 | 17.34 | 12.87 | 5.82 |
| Inventory Turnover | 3.44 | 1.30 | 1.56 | 2.51 | 0.97 |
| Fixed Asset Turnover | 2.13 | 2.66 | 2.22 | 2.59 | 2.64 |
| Asset Turnover | 0.57 | 0.72 | 0.59 | 0.67 | 0.71 |
| Working Capital Turnover Ratio | 1.03 | 1.42 | 1.20 | 1.60 | 1.99 |
| Cash Conversion Cycle | 117.76 | 267.30 | 241.57 | 158.83 | 372.49 |
| Days of Sales Outstanding | 31.06 | 23.78 | 29.19 | 42.06 | 60.50 |
| Days of Inventory Outstanding | 106.16 | 281.79 | 233.44 | 145.13 | 374.75 |
| Days of Payables Outstanding | 19.45 | 38.27 | 21.05 | 28.36 | 62.76 |
| Operating Cycle | 137.21 | 305.57 | 262.63 | 187.19 | 435.24 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 0.26 | 0.34 | 0.26 | 0.48 | 0.19 |
| Free Cash Flow Per Share | 0.23 | 0.23 | -0.04 | -0.02 | -0.07 |
| Dividend Paid and CapEx Coverage Ratio | 1.97 | 1.58 | 0.58 | 0.77 | 0.28 |
| Capital Expenditure Coverage Ratio | 8.56 | 2.91 | 0.87 | 0.95 | 0.72 |
| Operating Cash Flow Coverage Ratio | 0.56 | 0.57 | 0.20 | 0.28 | 0.10 |
| Operating Cash Flow to Sales Ratio | 0.09 | 0.09 | 0.07 | 0.10 | 0.04 |
| Free Cash Flow Yield | 7.83% | 6.51% | -0.73% | -0.49% | -0.85% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -19.27 | 26.77 | 26.30 | 26.55 | 339.35 |
| Price-to-Sales (P/S) Ratio | 1.05 | 0.92 | 1.39 | 1.05 | 1.68 |
| Price-to-Book (P/B) Ratio | 0.80 | 0.90 | 1.31 | 1.22 | 2.24 |
| Price-to-Free Cash Flow (P/FCF) Ratio | 12.78 | 15.36 | -137.85 | -204.29 | -117.51 |
| Price-to-Operating Cash Flow Ratio | 11.28 | 10.09 | 20.42 | 10.43 | 45.24 |
| Price-to-Earnings Growth (PEG) Ratio | 0.09 | -0.70 | 2.50 | 0.04 | -3.61 |
| Enterprise Value Multiple | -67.97 | 4.90 | 7.46 | 8.23 | 22.08 |
| Enterprise Value | 10.51M | 14.43M | 31.22M | 27.73M | 48.54M |
| EV to EBITDA | -67.97 | 4.90 | 7.46 | 8.23 | 22.08 |
| EV to Sales | 0.71 | 0.71 | 1.49 | 1.07 | 1.97 |
| EV to Free Cash Flow | 8.59 | 11.77 | -147.25 | -208.48 | -137.50 |
| EV to Operating Cash Flow | 7.58 | 7.73 | 21.82 | 10.64 | 52.93 |
| Tangible Book Value Per Share | 3.27 | 3.55 | 3.32 | 3.29 | 2.92 |
| Shareholders’ Equity Per Share | 3.63 | 3.88 | 4.13 | 4.10 | 3.74 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.09 | 0.32 | 0.28 | 0.37 | -0.08 |
| Revenue Per Share | 2.75 | 3.77 | 3.87 | 4.75 | 4.98 |
| Net Income Per Share | -0.15 | 0.13 | 0.21 | 0.19 | 0.02 |
| Tax Burden | 0.90 | 0.72 | 0.48 | 0.60 | 0.40 |
| Interest Burden | 0.69 | 0.90 | 0.93 | 0.91 | 0.64 |
| Research & Development to Revenue | 0.09 | 0.00 | 0.07 | 0.05 | 0.05 |
| SG&A to Revenue | 0.16 | 0.16 | 0.15 | 0.13 | 0.14 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | -1.69 | 2.85 | 1.29 | 2.55 | 7.50 |
Currency in EUR